MarketCap
Karyopharm Therapeutics KPTI
$ 0.42
18.35%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
10.9 K |
Market Cap[1] |
$ 4.59 K |
EBITDA (LTM) |
$ -90.4 M |
P/E (LTM) |
-0.099833 |
P/S (LTM) |
0.000134 |
EPS (LTM) |
-17.93 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Exicure
XCUR
|
$ 1.01 | 1.3 % | $ 6.36 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 0.97 | -2.17 % | $ 97.3 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 12.24 | 4.53 % | $ 3.66 B | Nasdaq Global Select Market |  Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.84 | -0.14 % | $ 7.87 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.21 | -2.18 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.37 | -3.04 % | $ 1.95 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.76 | -3.22 % | $ 45.9 M | Nasdaq Capital Market |  Israel |
 |
Jaguar Health
JAGX
|
$ 2.28 | -13.31 % | $ 5.32 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.57 | -2.65 % | $ 202 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 22.69 | -0.11 % | $ 1.3 B | Nasdaq Global Select Market |  Niderland |
 |
Stoke Therapeutics
STOK
|
$ 25.68 | -3.49 % | $ 1.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 25.16 | 0.88 % | $ 1.87 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.86 | 0.78 % | $ 599 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.89 | -0.02 % | $ 3.11 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 113.44 | -2.72 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 12.83 | 3.38 % | $ 15.5 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.86 | -1.1 % | $ 793 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 524.52 | 1.92 % | $ 134 B | Nasdaq Global Select Market,SPB | USA |
 |
AbbVie
ABBV
|
$ 284.8 | -1.45 % | $ 504 B | NYSE,SPB | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 31.87 | -2.89 % | $ 4.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.23 | -3.04 % | $ 196 M | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.18 | -3.46 % | $ 801 M | Nasdaq Global Select Market | Canada |
 |
Axon Enterprise
AXON
|
$ 402.6 | 2.54 % | $ 31.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 2.08 | 0.48 % | $ 118 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.05 | -0.65 % | $ 668 M | NYSE |  Britain |
 |
Catalyst Biosciences
CBIO
|
$ 13.17 | 0.77 % | $ 1.18 B | Nasdaq Capital Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.29 | 4.88 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
Cullinan Management
CGEM
|
$ 14.89 | 0.4 % | $ 897 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 2.12 | -0.93 % | $ 198 M | Nasdaq Global Market,SPB | Israel |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.81 | 1.06 % | $ 467 M | Nasdaq Global Select Market | USA |
 |
Cellectar Biosciences
CLRB
|
$ 1.28 | 4.07 % | $ 3.34 M | Nasdaq Capital Market | USA |
 |
Cocrystal Pharma
COCP
|
$ 0.96 | 1.81 % | $ 10.8 M | Nasdaq Capital Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 22.92 | -1.36 % | $ 725 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 4.29 | -3.05 % | $ 57.1 M | Nasdaq Global Market | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market | Israel |
 |
Curis
CRIS
|
$ 0.39 | -1.9 % | $ 5.13 M | Nasdaq Global Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.05 | -1.76 % | $ 794 M | Nasdaq Global Market | USA |
 |
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 25.33 | 3.73 % | $ 3.84 B | Nasdaq Global Select Market,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.51 | 1.31 % | $ 284 M | Nasdaq Capital Market | USA |
 |
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 18.68 | -1.32 % | $ 3.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Precision BioSciences
DTIL
|
$ 6.71 | 2.29 % | $ 86.1 M | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 37.18 | 1.47 % | $ 2.16 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.